Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:11:20 EDT Mon 06 May 2024
Enter Symbol
or Name
USA
CA



News for U:ANIP from 2023-05-07 to 2024-05-06 - 35 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-05-01 16:30U:ANIPNews ReleaseANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences
2024-04-18 16:05U:ANIPNews ReleaseANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET
2024-04-09 06:50U:ANIPNews ReleaseANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension
2024-04-04 06:50U:ANIPNews ReleaseANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis
2024-04-03 06:50U:ANIPNews ReleaseANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium
2024-03-27 06:50U:ANIPNews ReleaseANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP
2024-02-29 17:26U:ANIPSEDAR MD & ASEDAR MD & A
2024-02-29 17:25U:ANIPSEDAR Audited Annual Financial StatementsSEDAR Annual Report
2024-02-29 06:50U:ANIPNews ReleaseANI Pharmaceuticals Reports Fourth Quarter and Record Full-Year 2023 Financial Results and Provides 2024 Guidance
2024-02-20 06:50U:ANIPNews ReleaseANI Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference
2024-02-07 06:50U:ANIPNews ReleaseANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024, at 8:30 a.m. ET
2024-01-29 06:50U:ANIPNews ReleaseANI Pharmaceuticals to Participate at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
2024-01-23 06:50U:ANIPNews ReleaseANI Pharmaceuticals Announces the Launch of Pentoxifylline Extended-Release Tablets, USP
2024-01-16 06:50U:ANIPNews ReleaseANI Pharmaceuticals Announces the FDA Approval and Launch of Indomethacin Oral Suspension, USP
2023-11-22 09:27U:ANIPNews ReleaseANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference
2023-11-08 07:35U:ANIPSEDAR Interim MD & ASEDAR Interim MD & A
2023-11-08 07:33U:ANIPSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-08 06:50U:ANIPNews ReleaseANI Pharmaceuticals Reports Record Third Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance
2023-10-30 06:50U:ANIPNews ReleaseANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences
2023-10-25 06:50U:ANIPNews ReleaseANI Pharmaceuticals to Discuss Third Quarter 2023 Financial Results on November 8, 2023, at 8:30 a.m. ET
2023-10-02 06:50U:ANIPNews ReleaseANI Pharmaceuticals Announces FDA Approval and Commercial Availability of New 1-mL Vial Size of Purified Cortrophin ‚ ® Gel, Appropriate for Adjunctive Treatment of Certain Patients with Acute Gouty Arthritis Flares
2023-09-18 16:05U:ANIPNews ReleaseANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023
2023-09-12 06:50U:ANIPNews ReleaseANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Tablets USP
2023-08-28 06:50U:ANIPNews ReleaseANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.1%
2023-08-24 06:50U:ANIPNews ReleaseANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
2023-08-23 06:50U:ANIPNews ReleaseANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of Directors
2023-08-09 07:44U:ANIPSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-09 06:51U:ANIPNews ReleaseANI Pharmaceuticals Reports Record Second Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance ‚   ‚  
2023-07-31 07:17U:ANIPNews ReleaseANI Pharmaceuticals to Discuss Second Quarter 2023 Financial Results on August 9, 2023, at 8:30 a.m. ET
2023-05-31 16:21U:ANIPSEDAR MD & ASEDAR Interim Financial Statements
2023-05-16 16:05U:ANIPNews ReleaseANI Pharmaceuticals Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters ¢ € ™ Option to Purchase Additional Shares
2023-05-15 06:50U:ANIPNews ReleaseANI Pharmaceuticals Announces FDA Approval and Commercialization of Two ANDAs with CGT Exclusivity
2023-05-12 07:03U:ANIPNews ReleaseANI Pharmaceuticals Announces Pricing of $75 Million Public Offering of Common Stock
2023-05-11 16:01U:ANIPNews ReleaseANI Pharmaceuticals Announces Proposed Public Offering of Common Stock
2023-05-08 06:50U:ANIPNews ReleaseANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance